Paul Lucas
Chairman of the Board of Directors & Independent D
Nanotechnology
EcoSynthetix
Canada
Biography
Mr. Lucas served as President and CEO of GlaxoSmithKline Canada from 1994 until 2012, where he was responsible for all pharmaceutical operations in Canada. During his time with GSK, he built the company into a national manufacturing leader, producing and shipping more than CAD $2 billion worth of products, representing approximately 25 per cent of the total Canadian pharmaceutical shipments. Previous to joining Glaxo Canada in 1986, he held progressive management positions at Eli Lilly Canada and McNeil Pharmaceutical. Mr. Lucas sits on the Board of Directors for the Ontario Genomic Institute, was Chairman and member of the Board of Directors for TM Bioscience, was on the Board of Directors of the Toronto Regional Research Alliance and is a member of the Principal's Advisory Council of the University of Toronto at Mississauga. He served in the past as Chairman of the Board of Directors of Canada's Research-Based Pharmaceutical Companies (Rx&D). He received his B.Sc. (Honours) in Biology and Chemistry from Queen's University, and obtained his Chartered Directors designation (CDir) from the Directors College, a joint venture of McMaster University and the Conference Board of Canada, in 2009.
Research Interest
Business & Management
